Angel Adegbesan

Alamar Biosciences Inc., a maker of medical devices that detect protein biomarkers to diagnose diseases, raised $191 million in an upsized US initial public offering that priced at the top of a marketed range.

Alamar Biosciences Inc. shares climbed 33% on Friday after the medical device maker raised $191 million in an upsized US initial public offering that priced at the top of a marketed range.

Shares of companies involved in psychedelic-related therapies are surging in premarket trading Monday after President Donald Trump signed an executive order to expedite research and access.

Use precise geolocation data and actively scan device characteristics for identification.

(Bloomberg) -- Shares of companies involved in psychedelic-tied therapies are surging in Monday trading after President Donald Trump signed an executive order to expedite research and access.

Erasca Inc. shares plunged as much as 55% Tuesday after the cancer-drug developer said one patient withdrew from its clinical trial and later died after suffering severe side effects related to the treatment.

(Bloomberg) -- Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest

Mobia Medical Inc., a maker of medical devices to help stroke survivors, is seeking to raise as much as $160 million in a US initial public offering.

GMR Solutions Inc., an air and ground emergency medical services company, is seeking to raise as much as $797.9 million in a US initial public offering, joining a growing list of healthcare firms seeking to tap investors.

GMR Solutions Inc., an air and ground emergency medical services company that counts KKR & Co. among its backers, revised the terms of its IPO and is seeking to raise $479 million, down from an earlier target of as much as $798 million.